1. Home
  2. PRTC vs QUAD Comparison

PRTC vs QUAD Comparison

Compare PRTC & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • QUAD
  • Stock Information
  • Founded
  • PRTC 2015
  • QUAD 1971
  • Country
  • PRTC United States
  • QUAD United States
  • Employees
  • PRTC N/A
  • QUAD N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • QUAD Publishing
  • Sector
  • PRTC Health Care
  • QUAD Consumer Discretionary
  • Exchange
  • PRTC Nasdaq
  • QUAD Nasdaq
  • Market Cap
  • PRTC 509.0M
  • QUAD 409.1M
  • IPO Year
  • PRTC N/A
  • QUAD 2010
  • Fundamental
  • Price
  • PRTC $22.55
  • QUAD $7.01
  • Analyst Decision
  • PRTC Buy
  • QUAD Strong Buy
  • Analyst Count
  • PRTC 1
  • QUAD 2
  • Target Price
  • PRTC $45.00
  • QUAD $8.80
  • AVG Volume (30 Days)
  • PRTC 4.5K
  • QUAD 418.1K
  • Earning Date
  • PRTC 08-28-2024
  • QUAD 10-28-2024
  • Dividend Yield
  • PRTC N/A
  • QUAD 2.85%
  • EPS Growth
  • PRTC N/A
  • QUAD N/A
  • EPS
  • PRTC N/A
  • QUAD N/A
  • Revenue
  • PRTC $468,000.00
  • QUAD $2,751,700,000.00
  • Revenue This Year
  • PRTC N/A
  • QUAD N/A
  • Revenue Next Year
  • PRTC $139.60
  • QUAD N/A
  • P/E Ratio
  • PRTC N/A
  • QUAD N/A
  • Revenue Growth
  • PRTC N/A
  • QUAD N/A
  • 52 Week Low
  • PRTC $17.08
  • QUAD $4.06
  • 52 Week High
  • PRTC $34.00
  • QUAD $7.94
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 59.26
  • QUAD 57.47
  • Support Level
  • PRTC $20.61
  • QUAD $6.69
  • Resistance Level
  • PRTC $22.83
  • QUAD $7.94
  • Average True Range (ATR)
  • PRTC 0.69
  • QUAD 0.44
  • MACD
  • PRTC 0.04
  • QUAD -0.11
  • Stochastic Oscillator
  • PRTC 68.44
  • QUAD 25.20

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.

Share on Social Networks: